Usefulness of newly proposed albumin-bilirubin grade and its modification -Japan nationwide survey

Atsushi Hiraoka; Kojiro Michitaka; Takashi Kumada; Nobuhiro Izumi; M Kadoya; N. Kokudo; Shoji Kubo; Yoshinori Matsuyama; O Nakashima; Masaru Sakamoto; T. Takayama; Takashi Kokudo; Kenji Kashiwabara; Masatoshi Kudo

doi:10.1016/s0168-8278(18)31082-1

Related publications

Editorial Material2017

Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm

Masatoshi Kudo

Article2016

Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Reach Patients by Albumin-Bilirubin (ALBI) Grade

J.-F. Blanc, Stephen L. Chan, J.O. Park, Baek‐Yeol Ryoo, Chung‐Jen Yen, Masatoshi Kudo, Rtp Poon, Davide Pastorelli, Ari David Baron, Tatiana Pfiffer, Takuji Okusaka, Kateřina Kubáčková, Jörg Trojan, Javier Sastre, Ian Chau, Paolo Abada, Samuel Chang, Ling Yang, Alice Zhu

Article2019

Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan

Masatoshi Kudo, Namiki Izumi, Shoji Kubo, Norihiro Kokudo, Michiie Sakamoto, Shuichiro Shiina, Ryosuke Tateishi, Osamu Nakashima, Takamichi Murakami, Yutaka Matsuyama, Arata Takahashi, Hiroaki Miyata, Tadatoshi Takayama

Article2018

Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients

Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, Masatoshi Kudo

Article2021

Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)

Masatoshi Kudo, Namiki Izumi, Norihiro Kokudo, Michiie Sakamoto, Shuichiro Shiina, Tadatoshi Takayama, Ryosuke Tateishi, Osamu Nakashima, Takamichi Murakami, Yutaka Matsuyama, Arata Takahashi, Hiroaki Miyata, Shoji Kubo